Urgent.News

What's breaking now, across thousands of outlets.

Health & Medicine

FDA approves Revolution Medicines' first targeted drug for advanced pancreatic cancer

The drug, Rasonque, nearly doubled median overall survival compared with standard chemotherapy in a 500-patient trial

FDA approves Revolution Medicines' first targeted drug for advanced pancreatic cancer

We haven't written up this one. Quartz has the full story — the link below goes straight to it.

Also reported by 1 other outlet

Read the original at qz.com →

More in Health & Medicine

More from Wednesday 26 August →